STUDY OBJECTIVES: To assess the proportion of patients with obstructive sleep apnea hypopnea syndrome (OSAHS) reporting previous or current use and interest in future use of complementary and alternative medicine (CAM) therapies. DESIGN: Cross-sectional, point-of-care, anonymous survey. SETTING: Sleep disorders center at a Midwest tertiary care center. PARTICIPANTS: Six hundred forty-six consecutive patients undergoing polysomnography. MEASUREMENTS: The survey instrument comprised 45 items specifically related to CAM therapies, in addition to obtaining baseline data. RESULTS: Response rate was 81% (522/646). A total of 406/522 (78%) patients were diagnosed with OSAHS. Mean age +/- SD was 57 +/- 14 years, and 267 participants (66%) were men. Overall, 237 (58%) participants reported ever using CAM. Ever and current CAM use specifically for improving sleep was reported by 20% and 7% of the participants, respectively. Twenty-six percent of participants reported ever using biologic products, and 52% reported ever using nonbiologic CAM treatments. A high proportion (58%) of the participants showed interest in future CAM use for improving sleep. CONCLUSION: A high proportion of patients with OSAHS report previous or current use, and interest in future use, of CAM treatments. This underscores the need to conduct further research in this field.
STUDY OBJECTIVES: To assess the proportion of patients with obstructive sleep apnea hypopnea syndrome (OSAHS) reporting previous or current use and interest in future use of complementary and alternative medicine (CAM) therapies. DESIGN: Cross-sectional, point-of-care, anonymous survey. SETTING:Sleep disorders center at a Midwest tertiary care center. PARTICIPANTS: Six hundred forty-six consecutive patients undergoing polysomnography. MEASUREMENTS: The survey instrument comprised 45 items specifically related to CAM therapies, in addition to obtaining baseline data. RESULTS: Response rate was 81% (522/646). A total of 406/522 (78%) patients were diagnosed with OSAHS. Mean age +/- SD was 57 +/- 14 years, and 267 participants (66%) were men. Overall, 237 (58%) participants reported ever using CAM. Ever and current CAM use specifically for improving sleep was reported by 20% and 7% of the participants, respectively. Twenty-six percent of participants reported ever using biologic products, and 52% reported ever using nonbiologic CAM treatments. A high proportion (58%) of the participants showed interest in future CAM use for improving sleep. CONCLUSION: A high proportion of patients with OSAHS report previous or current use, and interest in future use, of CAM treatments. This underscores the need to conduct further research in this field.
Authors: Amy Lynn Meoli; Carol L Rosen; David Kristo; Michael Kohrman; Nalaka Gooneratne; Robert Neal Aguillard; Robert Fayle; Robert Troell Journal: Sleep Date: 2003-08-01 Impact factor: 5.849
Authors: Clete A Kushida; Timothy I Morgenthaler; Michael R Littner; Cathy A Alessi; Dennis Bailey; Jack Coleman; Leah Friedman; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Teofilo Lee-Chiong; Judith Owens; Jeffrey P Pancer Journal: Sleep Date: 2006-02 Impact factor: 5.849
Authors: Clete A Kushida; Michael R Littner; Max Hirshkowitz; Timothy I Morgenthaler; Cathy A Alessi; Dennis Bailey; Brian Boehlecke; Terry M Brown; Jack Coleman; Leah Friedman; Sheldon Kapen; Vishesh K Kapur; Milton Kramer; Teofilo Lee-Chiong; Judith Owens; Jeffrey P Pancer; Todd J Swick; Merrill S Wise Journal: Sleep Date: 2006-03 Impact factor: 5.849
Authors: Amanda Munoz-Casabella; Dietlind L Wahner-Roedler; Ivana T Croghan; Tanya M Petterson; Debbie L Fuehrer; Brent A Bauer Journal: Glob Adv Health Med Date: 2022-03-25